🏆 Finalist — NIH Data Sharing Index (“S-Index”) Challenge

Joel Beaudry

Memorial Sloan Kettering Cancer Center

ORCID: 0000-0002-8973-5139
Physics and AstronomyMedicine

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile
0Author DataRank

Indexed papers

0in pilot corpus
datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 4 papers. Top paper: “Combined brachytherapy and ultra-hypofractionated radiotherapy for intermediate-risk prostate cancer: Comparison of toxicity outcomes using a high-dose-rate (HDR) versus low-dose-rate (LDR) brachytherapy boost”.

Combined brachytherapy and ultra-hypofractionated radiotherapy for intermediate-risk prostate cancer: Comparison of toxicity outcomes using a high-dose-rate (HDR) versus low-dose-rate (LDR) brachytherapy boost

Brachytherapy(2022)10.1016/j.brachy.2022.04.006
N/A
0DataRank · unranked
20 citations

Daniel Gorovets, Jessica Flynn, Sean M. McBride, Victoria Brennan, Joel Beaudry +5 more

Instant plan quality prediction on transrectal ultrasound for high-dose-rate prostate brachytherapy

Brachytherapy(2024)10.1016/j.brachy.2024.10.009
N/A
0DataRank · unranked
0 citations

Yining Feng, Joel Beaudry, David Aramburu Núñez, Daniel Gorovets, Marisa Kollmeier +2 more

Quantifying geometric and dosimetric advantage from the use of rectal spacing in HDR prostate brachytherapy

Brachytherapy(2025)10.1016/j.brachy.2025.08.009
N/A
0DataRank · unranked
1 citations

Tonghe Wang, David Aramburu Núñez, Marisa Kollmeier, Daniel Gorovets, Shirin A. Enger +2 more

Automated daily check QA of treatment channel adjustments (TCA), active, and dummy source positioning using bravos after loader

Brachytherapy(2025)10.1016/j.brachy.2025.08.008
N/A
0DataRank · unranked
0 citations

Antonio D’Amato, David Aramburu Núñez, Joel Beaudry